Skip to main content

Peer Review reports

From: Baseline soluble MICA levels act as a predictive biomarker for the efficacy of regorafenib treatment in colorectal cancer

Original Submission
25 Dec 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
28 Jan 2022 Reviewed Reviewer Report - Nuri Faruk Aykan
11 Mar 2022 Reviewed Reviewer Report
16 Mar 2022 Author responded Author comments - Jun Arai
Resubmission - Version 3
16 Mar 2022 Submitted Manuscript version 3
20 Mar 2022 Reviewed Reviewer Report
29 Mar 2022 Author responded Author comments - Jun Arai
Resubmission - Version 4
29 Mar 2022 Submitted Manuscript version 4
Publishing
4 Apr 2022 Editorially accepted
20 Apr 2022 Article published 10.1186/s12885-022-09512-5

You can find further information about peer review here.

Back to article page